These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15479847)

  • 1. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.
    Giguère JF; Tremblay MJ
    J Virol; 2004 Nov; 78(21):12062-5. PubMed ID: 15479847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization.
    Fortin JF; Cantin R; Bergeron MG; Tremblay MJ
    Virology; 2000 Mar; 268(2):493-503. PubMed ID: 10704357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection.
    Fortin JF; Barbeau B; Hedman H; Lundgren E; Tremblay MJ
    Virology; 1999 Apr; 257(1):228-38. PubMed ID: 10208936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization.
    Hioe CE; Bastiani L; Hildreth JE; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S247-54. PubMed ID: 9814951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins.
    Beauséjour Y; Tremblay MJ
    Virology; 2004 Jun; 324(1):165-72. PubMed ID: 15183063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
    Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins could be used to control replication of some viruses, including HIV-1.
    Gilbert C; Bergeron M; Méthot S; Giguère JF; Tremblay MJ
    Viral Immunol; 2005; 18(3):474-89. PubMed ID: 16212526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context.
    Bounou S; Giguere JF; Cantin R; Gilbert C; Imbeault M; Martin G; Tremblay MJ
    FASEB J; 2004 Aug; 18(11):1294-6. PubMed ID: 15208262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.
    Tardif MR; Tremblay MJ
    J Virol; 2005 Nov; 79(21):13714-24. PubMed ID: 16227291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4.
    Liao Z; Roos JW; Hildreth JE
    AIDS Res Hum Retroviruses; 2000 Mar; 16(4):355-66. PubMed ID: 10716373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1-dependent mechanism.
    Fromentin R; Tardif MR; Tremblay MJ
    Virology; 2010 Mar; 398(2):168-75. PubMed ID: 20034651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locking a leukocyte integrin with statins.
    Frenette PS
    N Engl J Med; 2001 Nov; 345(19):1419-21. PubMed ID: 11794177
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.
    Weitz-Schmidt G; Welzenbach K; Brinkmann V; Kamata T; Kallen J; Bruns C; Cottens S; Takada Y; Hommel U
    Nat Med; 2001 Jun; 7(6):687-92. PubMed ID: 11385505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation.
    Raemer PC; Kohl K; Watzl C
    Eur J Immunol; 2009 Jun; 39(6):1456-65. PubMed ID: 19424968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
    Takahashi HK; Iwagaki H; Yagi T; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
    Clin Immunol; 2007 Jun; 123(3):324-32. PubMed ID: 17482516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.
    Fortin JF; Cantin R; Tremblay MJ
    J Virol; 1998 Mar; 72(3):2105-12. PubMed ID: 9499066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms that set the stage for DC-T cell engagement.
    van Gisbergen KP; Paessens LC; Geijtenbeek TB; van Kooyk Y
    Immunol Lett; 2005 Mar; 97(2):199-208. PubMed ID: 15752559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing the expression of LFA-1 and ICAM-1 as well as hindering their interaction as the major mechanism for statin-induced neutrophil dysfunction.
    Namazi MR
    Ann Thorac Surg; 2007 Dec; 84(6):2137-8. PubMed ID: 18036969
    [No Abstract]   [Full Text] [Related]  

  • 19. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.
    Bounou S; Leclerc JE; Tremblay MJ
    J Virol; 2002 Feb; 76(3):1004-14. PubMed ID: 11773376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.
    Paquette JS; Fortin JF; Blanchard L; Tremblay MJ
    J Virol; 1998 Nov; 72(11):9329-36. PubMed ID: 9765484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.